Subtopic Deep Dive
Low-Dose CT Screening for Lung Cancer
Research Guide
What is Low-Dose CT Screening for Lung Cancer?
Low-dose CT (LDCT) screening uses reduced radiation helical CT scans to detect early-stage lung cancer in high-risk smokers, reducing mortality by 20% as shown in the NLST trial (Aberle et al., 2011).
The National Lung Screening Trial (NLST) demonstrated 20% lung cancer mortality reduction with LDCT versus chest X-ray in 53,454 high-risk participants (Aberle et al., 2011; 10,624 citations). The Dutch-Belgian NELSON trial confirmed 25% mortality reduction with volume CT screening (de Koning et al., 2020; 3,212 citations). Key datasets like LIDC-IDRI enable nodule detection research (Armato et al., 2011; 2,623 citations).
Why It Matters
LDCT screening established USPSTF guidelines for annual screening in adults aged 50-80 with 20 pack-year history, implemented in millions and reducing population mortality (Krist et al., 2021). Risk models from PanCan study estimate nodule malignancy probability, guiding biopsy decisions and cutting unnecessary procedures (McWilliams et al., 2013). LIDC-IDRI dataset supports AI development for automated nodule analysis, improving radiologist accuracy (Armato et al., 2011). Cost-effectiveness analyses from NLST support program scalability (Gatsonis et al., 2010).
Key Research Challenges
Overdiagnosis in LDCT
LDCT detects indolent cancers that may not progress, inflating incidence without mortality benefit (Aberle et al., 2011). Balancing sensitivity and specificity remains critical in high-risk cohorts (de Koning et al., 2020).
Nodule Malignancy Prediction
Pulmonary nodules require accurate risk stratification to avoid overtreatment; PanCan model uses size, location, and patient factors (McWilliams et al., 2013). Validation across diverse populations is limited (Henschke, 2006).
Cost-Effectiveness Scaling
High false-positive rates drive follow-up costs, challenging program implementation (Gatsonis et al., 2010). NELSON trial shows lower rates but broader adoption needs economic modeling (de Koning et al., 2020).
Essential Papers
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Unknown, Denise R Aberle, Amanda M Adams et al. · 2011 · New England Journal of Medicine · 10.6K citations
Screening with the use of low-dose CT reduces mortality from lung cancer. (Funded by the National Cancer Institute; National Lung Screening Trial ClinicalTrials.gov number, NCT00047385.).
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis, Élisabeth Brambilla, Masayuki Noguchi et al. · 2011 · Journal of Thoracic Oncology · 4.8K citations
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch, Giorgio V. Scagliotti, James L. Mulshine et al. · 2016 · The Lancet · 3.3K citations
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong et al. · 2020 · New England Journal of Medicine · 3.2K citations
In this trial involving high-risk persons, lung-cancer mortality was significantly lower among those who underwent volume CT screening than among those who underwent no screening. There were low ra...
The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): A Completed Reference Database of Lung Nodules on CT Scans
Samuel G. Armato, Geoffrey McLennan, Luc Bidaut et al. · 2011 · Medical Physics · 2.6K citations
Purpose: The development of computer‐aided diagnostic (CAD) methods for lung nodule detection, classification, and quantitative assessment can be facilitated through a well‐characterized repository...
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
Claudia I. Henschke · 2006 · New England Journal of Medicine · 1.7K citations
Annual spiral CT screening can detect lung cancer that is curable.
Screening for Lung Cancer
Alex H. Krist, Karina W. Davidson, Carol M. Mangione et al. · 2021 · JAMA · 1.6K citations
The USPSTF recommends annual screening for lung cancer with LDCT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Scr...
Reading Guide
Foundational Papers
Start with NLST (Aberle et al., 2011) for mortality proof, NLST design (Gatsonis et al., 2010) for methods, LIDC-IDRI (Armato et al., 2011) for data, PanCan (McWilliams et al., 2013) for nodules.
Recent Advances
NELSON (de Koning et al., 2020) for volume CT confirmation; USPSTF update (Krist et al., 2021) for guidelines; CheXNeXt (Rajpurkar et al., 2018) for AI augmentation.
Core Methods
Helical LDCT at 120 kVp/30-60 mAs; nodule assessment via size (>6mm follow-up), PanCan probability (age, sex, nodules); CAD on LIDC-IDRI with deep learning.
How PapersFlow Helps You Research Low-Dose CT Screening for Lung Cancer
Discover & Search
Research Agent uses searchPapers and citationGraph on 'NLST Aberle 2011' to map 10,624 citing papers, revealing NELSON extensions (de Koning et al., 2020); exaSearch uncovers risk models like PanCan via 'low-dose CT nodule probability'.
Analyze & Verify
Analysis Agent applies readPaperContent to extract NLST mortality HR=0.80 from Aberle et al. (2011), then verifyResponse with CoVe and runPythonAnalysis for meta-analysis of NLST/NELSON HRs; GRADE grading assesses NLST as high-quality RCT evidence.
Synthesize & Write
Synthesis Agent detects gaps in overdiagnosis mitigation post-NLST, flagging contradictions between Henschke (2006) survival and Aberle (2011) harms; Writing Agent uses latexEditText, latexSyncCitations for NLST review, latexCompile for export, exportMermaid for screening workflow diagrams.
Use Cases
"Compare mortality reductions in NLST vs NELSON trials with confidence intervals"
Research Agent → searchPapers('NLST NELSON mortality') → Analysis Agent → readPaperContent(Aberle 2011, de Koning 2020) → runPythonAnalysis(pandas meta-analysis of HRs/CIs) → researcher gets GRADE-graded table with forest plot.
"Write LaTeX section on LDCT nodule guidelines citing PanCan and LIDC"
Synthesis Agent → gap detection('nodule management LDCT') → Writing Agent → latexEditText('draft guidelines') → latexSyncCitations(McWilliams 2013, Armato 2011) → latexCompile → researcher gets PDF with synced bibtex.
"Find code for lung nodule CAD from LIDC-IDRI papers"
Research Agent → searchPapers('LIDC-IDRI CAD github') → Code Discovery → paperExtractUrls(Armato 2011) → paperFindGithubRepo → githubRepoInspect → researcher gets annotated repo list with nodule detection scripts.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(250+ LDCT papers) → citationGraph(NLST cluster) → DeepScan(7-step: verify NLST claims via CoVe, Python survival analysis). Theorizer generates hypotheses on AI-reduced overdiagnosis from LIDC-IDRI + Rajpurkar (2018) CheXNeXt. Chain-of-Verification ensures zero hallucinations in mortality stats.
Frequently Asked Questions
What defines low-dose CT screening?
LDCT uses ≤1.5 mSv radiation for annual scans in high-risk smokers aged 55-74 with ≥30 pack-years, per NLST protocol (Aberle et al., 2011).
What methods prove LDCT efficacy?
Randomized trials NLST (20% mortality reduction, Aberle et al., 2011) and NELSON (25% reduction, de Koning et al., 2020); USPSTF endorses based on these (Krist et al., 2021).
What are key papers?
NLST (Aberle et al., 2011; 10k+ citations), NELSON (de Koning et al., 2020), LIDC-IDRI (Armato et al., 2011), PanCan nodules (McWilliams et al., 2013).
What open problems exist?
Reducing overdiagnosis/false-positives, refining risk models beyond PanCan for diverse groups, scaling cost-effective programs post-NLST/NELSON.
Research Lung Cancer Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Low-Dose CT Screening for Lung Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.